Invention Grant
- Patent Title: CRBN ligands and uses thereof
-
Application No.: US18059232Application Date: 2022-11-28
-
Publication No.: US11932635B2Publication Date: 2024-03-19
- Inventor: Nello Mainolfi , Nan Ji , Arthur F. Kluge
- Applicant: Kymera Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: Kymera Therapeutics, Inc.
- Current Assignee: Kymera Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Matthew C. Stevens
- The original application number of the division: US16961362
- Main IPC: C07D211/88
- IPC: C07D211/88 ; C07D239/22 ; C07D401/04 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D403/06 ; C07D413/04 ; C07D413/14 ; C07D417/04 ; C07D471/04 ; C07D487/04
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Public/Granted literature
- US20230234950A1 CRBN LIGANDS AND USES THEREOF Public/Granted day:2023-07-27
Information query
